1
|
Hu J, Li GF, Xu FM, Li Q, Lv T, Peng TF, Yin S, Gong W. Antibacterial lanostane triterpenoids from Ganoderma tsugae. J Asian Nat Prod Res 2024; 26:541-547. [PMID: 37796245 DOI: 10.1080/10286020.2023.2260749] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/08/2023] [Accepted: 09/15/2023] [Indexed: 10/06/2023]
Abstract
A phytochemical investigation on the 80% EtOH extract of the fruiting bodies of Ganoderma tsugae resulted into the isolation of two previously undescribed lanostane triterpenoids, 7,11-dioxo-3β-acetyloxy-26,27-dihydroxy-lanosta-8,24-diene (1) and 7,20-dioxo-3β-acetyloxy-11β,15α-dihydroxy-22,23,24,25,26,27-hexanorlanosta-8-ene (2), togeher with one known lanostane triterpenoid ganodermanontriol (3). Structural elucidation of all the compounds were performed by spectral methods such as 1D and 2D (1H-1H COSY, HMQC, and HMBC) NMR spectroscopy. All the triterpenoids were in vitro evaluated for their antibacterial activities against six pathogenic microorganisms. Compound 3 exhibited some activities against three Gram positive bacteria with MIC values less than 30 μg/ml.
Collapse
Affiliation(s)
- Jiang Hu
- College of Biological Resources and Food Engineering, Qujing Normal University, Qujing 655011, China
| | - Guo-Fen Li
- Maternal and Child Health and Family Planning Service Center of Zhanyi, Zhanyi 655331, China
| | - Feng-Ming Xu
- Department of Internal Neurology, The First People Hospital Of Qujing, Qujing 655000, China
| | - Qiang Li
- College of Biological Resources and Food Engineering, Qujing Normal University, Qujing 655011, China
| | - Tao Lv
- College of Biological Resources and Food Engineering, Qujing Normal University, Qujing 655011, China
| | - Tian-Feng Peng
- College of Biological Resources and Food Engineering, Qujing Normal University, Qujing 655011, China
| | - Si Yin
- College of Biological Resources and Food Engineering, Qujing Normal University, Qujing 655011, China
| | - Wei Gong
- Department of the Food and Drug Inspection, Shenyang Joint Logistics Support Center Drug Instrument Supervision and Inspection Station, Shenyang 110026, China
| |
Collapse
|
2
|
Lu S, Yu XM, Hu YP, Ma ZY, Li XY, Li WD, Liu YP, Wang D, Wang XW, Wang ZH, Wu JX, Zhong DS, Li GF, He WY, Bao YY, Yuan Y, Fan JH. [Response characteristics of tislelizumab combined with chemotherapy in first-line treatment of locally advanced or metastatic non-squamous non-small cell lung cancer]. Zhonghua Zhong Liu Za Zhi 2023; 45:358-367. [PMID: 37078218 DOI: 10.3760/cma.j.cn112152-20220928-00662] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 04/21/2023]
Abstract
Objective: To investigate the response characteristics of patients with locally advanced/metastatic non-squamous non-small cell lung cancer (nsq-NSCLC) treated with tislelizumab in combination with chemotherapy in the first line. Methods: Patients with nsq-NSCLC who achieved complete or partial remission after treatment with tislelizumab in combination with chemotherapy or chemotherapy alone in the RATIONALE 304 study, as assessed by an independent review board, were selected to analyze the response characteristics and safety profile of the responders. Time to response (TTR) was defined as the time from randomization to the achievement of first objective response. Depth of response (DpR) was defined as the maximum percentage of tumor shrinkage compared with the sum of the baseline target lesion length diameters. Results: As of January 23, 2020, 128 patients treated with tislelizumab in combination with chemotherapy achieved objective tumor response (responders), representing 57.4%(128/223) of the intention-to-treat population, with a TTR of 5.1 to 33.3 weeks and a median TTR of 7.9 weeks. Of the responders (128), 50.8%(65) achieved first remission at the first efficacy assessment (week 6), 31.3%(40) at the second efficacy assessment (week 12), and 18.0%(23) at the third and subsequent tumor assessments. The percentages of responders who achieved a depth of tumor response of 30% to <50%, 50% to <70% and 70% to 100% were 45.3%(58/128), 28.1%(36/128) and 26.6%(34/128), respectively, with median progression-free survival (PFS) of 9.0 months (95% CI: 7.7 to 9.9 months), 11.5 months (95% CI: 7.7 months to not reached) and not reached (95% CI: 11.8 months to not estimable), respectively. Tislelizumab plus chemotherapy were generally well tolerated in responders with similar safety profile to the overall safety population. Conclusion: Among responders to tislelizumab in combination with chemotherapy for nsq-NSCLC, 82.0%(105/128) achieves response within the first two tumor assessments (12 weeks) and 18.0%(23/128) achieves response at later (18 to 33 weeks) assessments, and there is a trend toward prolonged PFS in responders with deeper tumor response.
Collapse
Affiliation(s)
- S Lu
- Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, China
| | - X M Yu
- Department of Thoracic Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, China
| | - Y P Hu
- Department of Thoracic Oncology, Hubei Cancer Hospital, Wuhan 430079, China
| | - Z Y Ma
- Department of Respiratory Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou University, Zhengzhou 450003, China
| | - X Y Li
- Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
| | - W D Li
- Department of Medical Oncology, Affiliated Cancer Hospital of Guangzhou Medical University, Guangzhou 510095, China
| | - Y P Liu
- Department of Medical Oncology, The First Hospital of China Medical University, Shenyang 110001, China
| | - D Wang
- Department of Oncology, Army Sepcialty Medical Center, Chongqing 400042, China
| | - X W Wang
- Department of Medical Oncology, Qilu Hospital of Shandong University, Jinan 250012, China
| | - Z H Wang
- Department of Medical Oncology, Shandong Cancer Hospital, Jinan 250117, China
| | - J X Wu
- Department of Medical Oncology, The First Affiliated Hospital of Xiamen University, Xiamen 361003, China
| | - D S Zhong
- Department of Medical Oncology, Tianjin Medical University General Hospital, Tianjin 300052, China
| | - G F Li
- Department of Thoracic Surgery, Yunnan Cancer Hospital, Kunming 650118, China
| | - W Y He
- BeiGene (Beijing) Co., Ltd., Beijing 100022, China
| | - Y Y Bao
- BeiGene (Shanghai) Co., Ltd., Shanghai 200020, China
| | - Y Yuan
- BeiGene (Shanghai) Co., Ltd., Shanghai 200020, China
| | - J H Fan
- BeiGene (Beijing) Co., Ltd., Beijing 100022, China
| |
Collapse
|
3
|
Wang XD, Liu X, Wu T, Yang Y, Qi SN, He X, Zhang LL, Wu G, Qu BL, Qian LT, Hou XR, Zhang FQ, Qiao XY, Wang H, Li GF, Zhu Y, Cao JZ, Wu JX, Zhu SY, Shi M, Su H, Zhang XM, Zhang HL, Huang HQ, Zhang YJ, Song YQ, Zhu J, Wang Y, Li YX. [Outcome of radiotherapy for low-risk early-stage patients with extranodal NK/T-cell lymphoma, nasal-type]. Zhonghua Zhong Liu Za Zhi 2021; 43:1105-1113. [PMID: 34695903 DOI: 10.3760/cma.j.cn112152-20200924-00851] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To evaluate the prognosis and determine the failure patterns after radiotherapy for low-risk early-stage patients with extranodal NK/T-cell lymphoma, nasal-type (ENKTCL). Methods: A total of 557 patients from 2000-2015 with low-risk early-stage ENKTCL who received radiotherapy (RT) with or without chemotherapy (CT) from China Lymphoma Collaborative Group were retrospectively reviewed. Among them, 427 patients received combined modality therapy, whereas 130 patients received RT alone. Survivals were calculated by Kaplan-Meier method and compared with Log-rank test. Overall survival (OS) was compared with age and sex-matched general Chinese population using expected survival and standardized mortality ratio (SMR). Cox stepwise regression model was used for multivariate analysis. Results: The 5-year OS and progression-free survival (PFS) were 87.2% and 77.2%. The SMR was 3.59 (P<0.001) at 1 year after treatment, whereas it was 1.50 at 4 years after treatment, without significant difference between ENKTCL group and country-matched general population (P=0.146). Compared with RT alone, CMT did not result in significantly superior 5-year OS (87.0% vs 87.4%, P=0.961) or PFS (76.1% vs 80.7%, P=0.129). Local failure (11.5%, 64/557) and distant failure (10.8%, 60/557) were the main failure modes, while regional failure was rare (2.9%, 16/557). The 5-year locoregional control rate (LRC) was 87.2% for the whole group, with 89.5% for ≥50 Gy versus 73.7% for <50 Gy (P<0.001). Radiotherapy dose was an independent factor affecting LRC(P<0.05). Conclusions: Radiotherapy achieves a favorable prognosis in patients with low-risk early-stage ENKTCL. The incidence of either locoregional or distant failure is low. Radiation dose still is an important prognostic factor for LRC.
Collapse
Affiliation(s)
- X D Wang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| | - X Liu
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| | - T Wu
- Department of Radiation Oncology, Affiliated Hospital of Guizhou Medical University/Guizhou Cancer Hospital, Guiyang 550000, China
| | - Y Yang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| | - S N Qi
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| | - X He
- Department of Radiation Oncology, Jiangsu Cancer Hospital/Nanjing Medical University Affiliated Cancer Hospital, Nanjing 210009, China
| | - L L Zhang
- Department of Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430023, China
| | - G Wu
- Department of Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430023, China
| | - B L Qu
- Department of Radiation Oncology, The General Hospital of Chinese People's Liberation Army, Beijing 100853, China
| | - L T Qian
- Department of Radiation Oncology, the First Affiliated Hospital of University of Science and Technology of China/Anhui Provincial Hospital, Hefei 230001, China
| | - X R Hou
- Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| | - F Q Zhang
- Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| | - X Y Qiao
- Department of Radiation Oncology, Hebei Cancer Hospital/the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China
| | - H Wang
- Department of Radiation Oncology, Second Affiliated Hospital of Nanchang University, Nanchang 330006, China
| | - G F Li
- Department of Radiation Oncology, Beijing Hospital, Beijing 100730, China
| | - Y Zhu
- Department of Radiation Oncology, Zhejiang Cancer Hospital/Cancer Hospital of The University of Chinese Academy of Sciences, Hangzhou 310022, China
| | - J Z Cao
- Department of Radiation Oncology, Shanxi Cancer Hospital and the Affiliated Cancer Hospital of Shanxi Medical University, Taiyuan 030001, China
| | - J X Wu
- Department of Radiation Oncology, Fujian Provincial Cancer Hospital/Affiliated Cancer Hospital of Fujian Medical University, Fuzhou 350014, China
| | - S Y Zhu
- Department of Radiation Oncology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha 410013, China
| | - M Shi
- Department of Radiation Oncology, Xijing Hospital, the Fourth Military Medical University, Xi'an 710032, China
| | - H Su
- Department of Oncology, the Fifth Medical Center of PLA General Hospital, Affiliated Hospital of PLA Academy of Military Medical Sciences, Beijing 100071, China
| | - X M Zhang
- Department of Radiation Oncology, Key Laboratory of Cancer Prevention and Therapy/Tianjin Medical University Cancer Institute & Hospital/National Clinical Research Center for Cancer, Tianjin 300060, China
| | - H L Zhang
- Department of Lymphoma, Key Laboratory of Cancer Prevention and Therapy/Tianjin Medical University Cancer Institute & Hospital/National Clinical Research Center for Cancer, Tianjin 300060, China
| | - H Q Huang
- Departments of Radiation Oncology, State Key Laboratory of Oncology in South China/Sun Yat-sen University Cancer Center/Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China
| | - Y J Zhang
- Departments of Medical Oncology, State Key Laboratory of Oncology in South China/Sun Yat-sen University Cancer Center/Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China
| | - Y Q Song
- Department of Radiation Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education)/Peking University Cancer Hospital & Institute, Beijing 100142, China
| | - J Zhu
- Department of Radiation Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education)/Peking University Cancer Hospital & Institute, Beijing 100142, China
| | - Y Wang
- Department of Radiation Oncology, Chongqing Cancer Hospital, Chongqing 400000, China
| | - Y X Li
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| |
Collapse
|
4
|
Wang XM, Wang L, Wang X, Chen JQ, Li C, Zhang WC, Ge XL, Shen WB, Hu MM, Yuan QQ, Xu YG, Hao CL, Zhou ZG, Qie S, Lu N, Han C, Pang QS, Wang P, Sun XC, Zhang KX, Li GF, Li L, Liu ML, Wang YD, Qiao XY, Zhu SC, Zhou ZM, Zhao YD, Xiao ZF. [Long-term efficacy and safety of simultaneous integrated boost radiotherapy in non-operative esophageal squamous cell carcinoma: a multicenter retrospective data analysis (3JECROG R-05)]. Zhonghua Zhong Liu Za Zhi 2021; 43:889-896. [PMID: 34407597 DOI: 10.3760/cma.j.cn112152-20190412-00234] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To analyze the survival benefits and treatment related toxic effects of simultaneous integrated boost intensity-modulated radiotherapy (SIB-RT) for non-operative esophageal squamous cell carcinoma patients. Methods: The data of 2 132 ESCC patients who were not suitable for surgery or rejected operation, and underwent radical radiotherapy from 2002 to 2016 in 10 hospitals of Jing-Jin-Ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group (3JECROG) were analyzed. Among them, 518 (24.3%) cases underwent SIB (SIB group) and 1 614 (75.7%) cases did not receive SIB (No-SIB group). The two groups were matched with 1∶2 according to propensity score matching (PSM) method (caliper value=0.02). After PSM, 515 patients in SIB group and 977 patients in No-SIB group were enrolled. Prognosis and treatment related adverse effects of these two groups were compared and the independent prognostic factor were analyzed. Results: The median follow-up time was 61.7 months. Prior to PSM, the 1-, 3-, and 5-years overall survival (OS) rates of SIB group were 72.2%, 42.8%, 35.5%, while of No-SIB group were 74.3%, 41.4%, 31.9%, respectively (P=0.549). After PSM, the 1-, 3-, and 5-years OS rates of the two groups were 72.5%, 43.4%, 36.4% and 75.3%, 41.7%, 31.6%, respectively (P=0.690). The univariate survival analysis of samples after PSM showed that the lesion location, length, T stage, N stage, TNM stage, simultaneous chemoradiotherapy, gross tumor volume (GTV) and underwent SIB-RT or not were significantly associated with the prognosis of advanced esophageal carcinoma patients who underwent radical radiotherapy (P<0.05). Cox model multivariate regression analysis showed lesion location, TNM stage, GTV and simultaneous chemoradiotherapy were independent prognostic factors of advanced esophageal carcinoma patients who underwent radical radiotherapy (P<0.05). Stratified analysis showed that, in the patients whose GTV volume≤50 cm(3), the median survival time of SIB and No-SIB group was 34.7 and 30.3 months (P=0.155), respectively. In the patients whose GTV volume>50 cm(3), the median survival time of SIB and No-SIB group was 16.1 and 20.1 months (P=0.218). The incidence of radiation esophagitis and radiation pneumonitis above Grade 3 in SIB group were 4.3% and 2.5%, significantly lower than 13.1% and 11% of No-SIB group (P<0.001). Conclusions: The survival benefit of SIB-RT in patients with locally advanced esophageal carcinoma is not inferior to non-SIB-RT, but without more adverse reactions, and shortens the treatment time. SIB-RT can be used as one option of the radical radiotherapy for locally advanced esophageal cancer.
Collapse
Affiliation(s)
- X M Wang
- Department of Radiation Oncology, Anyang Cancer Hospital, Anyang 455000, China
| | - L Wang
- Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China
| | - X Wang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| | - J Q Chen
- Department of Radiation Oncology, Fujian Cancer Hospital/Fujian Medical University Cancer Hospital, Fuzhou 350014, China
| | - C Li
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| | - W C Zhang
- Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital/National Clinical Research Center for Cancer, Tianjin 300060, China
| | - X L Ge
- Department of Radiation Oncology, Jiangsu People's Hospital/the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
| | - W B Shen
- Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China
| | - M M Hu
- Department of Radiation Oncology, Tengzhou Central People's Hospital, Tengzhou 277599, China
| | - Q Q Yuan
- Department of Radiation Oncology, Tengzhou Central People's Hospital, Tengzhou 277599, China
| | - Y G Xu
- Department of Radiation Oncology, Beijing Hospital, National Center of Gerontology, Beijing 100730, China
| | - C L Hao
- Department of Radiation Oncology, Tengzhou Central People's Hospital, Tengzhou 277599, China
| | - Z G Zhou
- Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China
| | - S Qie
- Department of Radiation Oncology, Affiliated Hospital of Hebei University, Baoding 071000, China
| | - N Lu
- Department of Radiation Oncology, the 7th Medical Center of PLA Army General Hospital, Beijing 100700, China
| | - C Han
- Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China
| | - Q S Pang
- Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital/National Clinical Research Center for Cancer, Tianjin 300060, China
| | - P Wang
- Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital/National Clinical Research Center for Cancer, Tianjin 300060, China
| | - X C Sun
- Department of Radiation Oncology, Jiangsu People's Hospital/the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
| | - K X Zhang
- Department of Radiation Oncology, Tengzhou Central People's Hospital, Tengzhou 277599, China
| | - G F Li
- Department of Radiation Oncology, Beijing Hospital, National Center of Gerontology, Beijing 100730, China
| | - L Li
- Department of Radiation Oncology, Tengzhou Central People's Hospital, Tengzhou 277599, China
| | - M L Liu
- Department of Radiation Oncology, Affiliated Hospital of Hebei University, Baoding 071000, China
| | - Y D Wang
- Department of Radiation Oncology, the 7th Medical Center of PLA Army General Hospital, Beijing 100700, China
| | - X Y Qiao
- Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China
| | - S C Zhu
- Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China
| | - Z M Zhou
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| | - Y D Zhao
- Department of Radiation Oncology, Anyang Cancer Hospital, Anyang 455000, China
| | - Z F Xiao
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| |
Collapse
|
5
|
Nong Y, Lin JT, Sun XW, Wang J, Ma X, Liu XP, Wang HQ, Zha RT, Shen DP, Jiang SJ, Luo SK, Zhao Q, Meng L, Wang WP, Fang J, Han LM, Lu GB, Zhang W, Li GF, Wang H, Zhao ZY, Zhou W, Wei BL, Yuan YD, Peng LP, Lu XL, Pang GF, Li FH, Li L, Zhen H. [Efficacy and safety of Kangbingdu granules in the treatment of influenza: a randomized, double-blind, double-dummy, positive-drug parallel control multicenter clinical trial]. Zhonghua Yi Xue Za Zhi 2021; 101:205-211. [PMID: 33370867 DOI: 10.3760/cma.j.cn112137-20201122-03166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To observe the efficacy and safety of Kangbingdu granules (KBD) in the treatment of influenza. Methods: A multicenter, randomized, double-blind, double-dummy, and positive-drug parallel control trial was conducted in 27 Grade ⅢA hospitals in China and the subjects were randomly assigned to the KBD test group or the oseltamivir phosphate capsule control group at a ratio of 1∶1. 200 subjects were planned to be enrolled in each group. The experimental group was given KBD (18g each time, 3 times a day) and oseltamivir phosphate simulator orally, while the control group was given oseltamivir phosphate capsule (75 mg each time, twice a day) and KBD simulator orally for 5 days. The primary efficacy indicators included the remission time of major clinical symptoms and the time of complete defervescence. The secondary efficacy indicators included dosage of acetaminophen, the change of traditional Chinese medicine (TCM) syndrome score and the remission time of other important clinical symptoms. The efficacy of KBD in the test group and Oseltamivir phosphate control group were compared. Adverse events or adverse reactions were observed at the same time to evaluate the safety of KBD Granules. Results: A total of 393 subjects from 27 Grade ⅢA hospitals in China were enrolled. The experimental group included 195 subjects and 191 subjects (97.95%) completed the trial, While the control group included 198 subjects and 195 subjects (98.48%) completed the trial. There was no significant difference in the shedding rate and rejection rate between the two groups (P>0.05). In the Full Analysis Set (FAS), the mean age of the experimental group was (34.9±14.4) years old, with 83 males (42.78%). The mean age of the control group was (33.3±13.5) years old, with 78 males (39.59%). There were no statistically significant differences between the two groups in demographic data, physical examination, viral pathogen detection, total score of TCM syndromes and scores of each symptom at baseline (P>0.05). In the FAS, the remission time M (Q1, Q3) of major clinical symptoms was 3.0 (3.0, 4.0) days in the experimental group and 3.0 (3.0, 4.0) days in the control group, and the difference was not statistically significant (P>0.05). The time M (Q1, Q3) of complete defervescence was 34.0 (20.3, 49.0) hours in the experimental group and 36.5 (19.6, 48.8) hours in the control group, and the difference was not statistically significant (P>0.05). KBD granules had the same effect as Oseltamivir phosphate capsule (P>0.05) in terms of acetaminophen dosage, TCM syndrome effect and disappearance rate of most important clinical symptoms. Meanwhile, the disappearance rate of dizziness and chest distress on day 3 in the KBD granules group was better than that of oseltamivir phosphate capsule (P<0.05). Conclusion: KBD granules have the same efficacy as Oseltamivir Phosphate capsule in the treatment of influenza and the drug safety is good.
Collapse
Affiliation(s)
- Y Nong
- Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China
| | - J T Lin
- Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China
| | - X W Sun
- Department of Lung Diseases, Mudanjiang Hospital of Traditional Chinese Medicine, Mudanjiang 157009, China
| | - J Wang
- Department of Pulmonary and Critical Care Medicine, the Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250001, China
| | - X Ma
- Emergency Department, Luohe Hospital of traditional Chinese Medicine, Luohe 462000, China
| | - X P Liu
- Department of Pulmonary and Critical Care Medicine, the Second People's Hospital of Gansu Province, Lanzhou 730030, China
| | - H Q Wang
- Respiratory Department, the Second Affiliated Hospital of Shanxi University of traditional Chinese Medicine, Xianyang 712021, China
| | - R T Zha
- Respiratory Department of Wuhu First people's Hospital, Wuhu 241000, China
| | - D P Shen
- Department of Internal Medicine, Zaozhuang Maternal and Child Health Hospital, Zaozhuang 277800, China
| | - S J Jiang
- Department of Pulmonary and Critical Care Medicine, Shandong Provincial Hospital, Jinan 250021, China
| | - S K Luo
- Department of Internal Medicine, Urumqi Hospital of Traditional Chinese Medicine, Urumqi 830000, China
| | - Q Zhao
- Department of Respiratory Medicine, Heilongjiang Red Cross (Forest Industry General) Hospital, Haerbin 150040, China
| | - L Meng
- Department of Pulmonary and Critical Care medicine, the Second Affiliated Hospital of Shandong First Medical University, Taian 271000, China
| | - W P Wang
- Department of Respiratory Medicine, Changzhi People's Hospital, Changzhi 046000, China
| | - J Fang
- Department of Respiratory Medicine, Dezhou People's Hospital, Dezhou 253020, China
| | - L M Han
- Department of Respiratory Medicine, the Second Affiliated Hospital of Xinjiang Medical University, Urumqi 830063, China
| | - G B Lu
- Department of Pulmonary and Critical Care Medicine, Meishan Hospital of Traditional Chinese Medicine, Meishan 620010, China
| | - W Zhang
- Department of Lung Diseases, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China
| | - G F Li
- Respiratory Department of General Hospital of Jizhou Energy Fengfeng Group Co., Ltd, Handan 056011, China
| | - H Wang
- Department of Respiratory Medicine, Mudanjiang First People's Hospital, Mudanjiang 157011, China
| | - Z Y Zhao
- Respiratory Department of Baoding Second Hospital, Baoding 071051, China
| | - W Zhou
- Department of Pulmonary and Critical Care Medicine, General Hospital of Ningxia Medical University, Yinchuan 750003, China
| | - B L Wei
- Department of Pulmonary and Critical Care Medicine, the Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300250, China
| | - Y D Yuan
- Department of Pulmonary and Critical Care Medicine, the Second Hospital of Hebei Medical University, Shijiazhuang 050000, China
| | - L P Peng
- Department of Pulmonary and Critical Care Medicine, the First Hospital of Jilin University, Changchun 130021, China
| | - X L Lu
- Department of Respiratory Medicine, the First Affiliated Hospital of Medical College of Shihezi University, Shihezi 832008, China
| | - G F Pang
- Department of Pulmonary and Critical Care medicine, Affiliated Hospital of Chengde Medical College, Chengde 067000, China
| | - F H Li
- Department of Respiratory Medicine, Weinan Central Hospital, Weinan 714000, China
| | - L Li
- Technical Center for Drug Research and Evaluation of China Association of Traditional Chinese Medicine, Beijing 100101, China
| | - H Zhen
- Technical Center for Drug Research and Evaluation of China Association of Traditional Chinese Medicine, Beijing 100101, China
| |
Collapse
|
6
|
Hu MM, Yuan QQ, Zhang XS, Yang S, Wang X, Wang L, Chen JQ, Zhang WC, Wang XM, Ge XL, Shen WB, Xu YG, Hao CL, Zhou ZG, Qie S, Lu N, Pang QS, Zhao YD, Sun XC, Li GF, Li L, Qiao XY, Liu ML, Wang YD, Li C, Zhu SC, Han C, Zhang KX, Xiao ZF. [Efficacy analysis of the radiotherapy and chemotherapy in patients with stage Ⅳ esophageal squamous carcinoma: a multicenter retrospective study of Jing-Jin-Ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group (3JECROG R-01F)]. Zhonghua Zhong Liu Za Zhi 2020; 42:676-681. [PMID: 32867461 DOI: 10.3760/cma.j.cn112152-20190327-00197] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To evaluate the survival and prognostic factors of radiotherapy in patient with Ⅳ stage esophageal squamous carcinoma treated with radiation or chemoradiation. Methods: The medical records of 608 patients with stage Ⅳ esophageal squamous cell carcinoma who met the inclusion criteria in 10 medical centers in China from 2002 to 2016 were retrospectively analyzed. The overall survival and prognostic factors of all patients at 1, 3 and 5 years were analyzed. Results: The 1-, 3-, 5- year overall survival (OS) rates was 66.7%, 29.5% and 24.3% in stage ⅣA patients, and 58.8%, 29.0% and 23.5% in stage ⅣB patients. There was no statistical difference between the two groups (P=0.255). Univariate analysis demonstrated that the length of lesion, treatment plan, planned tumor target volume (PGTV) dose, subsequent chemotherapy, and degrees of anemia, radiation esophagitis, radiation pneumonia were related to the prognoses of patients with Ⅳ stage esophageal carcinomas after radiotherapy and chemotherapy (P<0.05). Multivariate analysis demonstrated that PGTV dose (OR=0.693, P=0.004), radiation esophagitis (OR=0.867, P=0.038), and radiation pneumonia (OR=1.181, P=0.004) were independent prognostic factors for OS. Conclusions: For patients with stage Ⅳ esophageal squamous cell carcinoma, chemoradiotherapy followed by sequential chemotherapy is recommended, which can extend the total survival and improve the prognosis of the patients. PGTV dose more than 60 Gy has better efficacy.
Collapse
Affiliation(s)
- M M Hu
- Department of Oncology, Tengzhou Central People's Hospital, Tengzhou, 277599, China
| | - Q Q Yuan
- Department of Oncology, Tengzhou Central People's Hospital, Tengzhou, 277599, China
| | - X S Zhang
- Department of Oncology, Tengzhou Central People's Hospital, Tengzhou, 277599, China
| | - S Yang
- Department of Oncology, Tengzhou Central People's Hospital, Tengzhou, 277599, China
| | - X Wang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| | - L Wang
- Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China
| | - J Q Chen
- Department of Radiation Oncology, Fujian Cancer Hospital/Fujian Medical University Cancer Hospital, Fuzhou 350014, China
| | - W C Zhang
- Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital/National Clinical Research Center for Cancer, Tianjin 300060, China
| | - X M Wang
- Department of Radiation Oncology, Anyang Cancer Hospital, Anyang 455000, China
| | - X L Ge
- Department of Radiation Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
| | - W B Shen
- Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China
| | - Y G Xu
- Department of Radiation Oncology, Beijing Hospital, National Center of Gerontology Beijing 100730, China
| | - C L Hao
- Department of Oncology, Tengzhou Central People's Hospital, Tengzhou, 277599, China
| | - Z G Zhou
- Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China
| | - S Qie
- Department of Radiation Oncology, Affiliated Hospital of Hebei University, Baoding 071000, China
| | - N Lu
- Department of Radiation Oncology, the Seventh Medical Center of PLA General Hospital, Beijing 100700, China
| | - Q S Pang
- Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital/National Clinical Research Center for Cancer, Tianjin 300060, China
| | - Y D Zhao
- Department of Radiation Oncology, Anyang Cancer Hospital, Anyang 455000, China
| | - X C Sun
- Department of Radiation Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
| | - G F Li
- Department of Radiation Oncology, Beijing Hospital, National Center of Gerontology Beijing 100730, China
| | - L Li
- Department of Oncology, Tengzhou Central People's Hospital, Tengzhou, 277599, China
| | - X Y Qiao
- Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China
| | - M L Liu
- Department of Radiation Oncology, Affiliated Hospital of Hebei University, Baoding 071000, China
| | - Y D Wang
- Department of Radiation Oncology, the Seventh Medical Center of PLA General Hospital, Beijing 100700, China
| | - C Li
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| | - S C Zhu
- Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China
| | - C Han
- Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China
| | - K X Zhang
- Department of Oncology, Tengzhou Central People's Hospital, Tengzhou, 277599, China
| | - Z F Xiao
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| |
Collapse
|
7
|
Lu N, Wang X, Li C, Wang L, Chen JQ, Zhang WC, Wang XM, Ge XL, Shen WB, Hu MM, Yuan QQ, Xu YG, Hao CL, Zhou ZG, Qie S, Xiao ZF, Zhu SC, Han C, Qiao XY, Pang QS, Wang P, Zhao YD, Sun XC, Zhang KX, Li L, Li GF, Liu ML, Wang YD. [Prognostic analysis of definitive radiotherapy for early esophageal carcinoma(T1-2N0M0): a multi-center retrospective study of Jing-Jin-ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group]. Zhonghua Zhong Liu Za Zhi 2020; 42:139-144. [PMID: 32135649 DOI: 10.3760/cma.j.issn.0253-3766.2020.02.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To evaluate the prognostic factors of T1-2N0M0 esophageal squamous cell carcinoma (ESCC) treated with definitive radiotherapy. Methods: The clinical data of 196 patients with T1-2N0M0 ESCC who were treated with definitive radiotherapy in 10 hospitals were retrospectively analyzed. All sites were members of Jing-Jin-Ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group (3JECROG). Radiochemotherapy were applied to 78 patients, while the other 118 patients received radiotherapy only. 96 patients were treated with three-dimensional conformal radiotherapy (3DCRT) and 100 treated with intensity-modulated radiotherapy (IMRT). The median dose of plan target volume(PTV) and gross target volume(GTV) were both 60 Gy. The median follow-up time was 59.2 months. Log rank test and Cox regression analysis were used for univariat and multivariate analysis, respectively. Results: The percentage of normal lung receiving at least 20 Gy (V(20)) was (18.65±7.20)%, with average dose of (10.81±42.05) Gy. The percentage of normal heart receiving at least 30 Gy (V(30)) was (14.21±12.28)%. The maximum dose of exposure in spinal cord was (39.65±8.13) Gy. The incidence of radiation pneumonia and radiation esophagitis were 14.80%(29/196) and 65.82%(129/196), respectively. The adverse events were mostly grade 1-2, without grade 4 toxicity. Median overall survival (OS) and progression-free survival (PFS) were 70.1 months and 62.3 months, respectively. The 1-, 3- and 5-year OS rates of all patients were 75.1%、57.4% and 53.2%, respectively. The 1-, 3- and 5-year PFS rates were 75.1%、57.4% and 53.2%, respectively. Multivariate analysis demonstrated that patients'age (HR=1.023, P=0.038) and tumor diameter (HR=1.243, P=0.028)were the independent prognostic factors for OS, while tumor volume were the independent prognostic factor for PFS. Conclusions: Definitive radiotherapy is a promising therapeutic method in patients with T1-2N0M0 ESCC. Patients' age, tumor diameter and tumor volume may impact patients' prognosis.
Collapse
Affiliation(s)
- N Lu
- Department of Radiation Oncology, the Seventh Medical Center of PLA General Hospital, Beijing 100700, China
| | - X Wang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| | - C Li
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| | - L Wang
- Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China
| | - J Q Chen
- Department of Radiation Oncology, Fujian Cancer Hospital/Fujian Medical University Cancer Hospital, Fuzhou 350014, China
| | - W C Zhang
- Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital/National Clinical Research Center for Cancer, Tianjin 300060, China
| | - X M Wang
- Department 4th of Radiation Oncology, Anyang Cancer Hospital, Anyang 455000, China
| | - X L Ge
- Department of Radiation Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
| | - W B Shen
- Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China
| | - M M Hu
- Department of Oncology, Tengzhou Central People's Hospital, Tengzhou 277599, China
| | - Q Q Yuan
- Department of Oncology, Tengzhou Central People's Hospital, Tengzhou 277599, China
| | - Y G Xu
- Department of Radiation Oncology, Beijing Hospital, National Center of Gerontology, Beijing 100730, China
| | - C L Hao
- Department of Oncology, Tengzhou Central People's Hospital, Tengzhou 277599, China
| | - Z G Zhou
- Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China
| | - S Qie
- Department of Radiation Oncology, Affiliated Hospital of Hebei University, Baoding 071000, China
| | - Z F Xiao
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| | - S C Zhu
- Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China
| | - C Han
- Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China
| | - X Y Qiao
- Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China
| | - Q S Pang
- Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital/National Clinical Research Center for Cancer, Tianjin 300060, China
| | - P Wang
- Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital/National Clinical Research Center for Cancer, Tianjin 300060, China
| | - Y D Zhao
- Department 4th of Radiation Oncology, Anyang Cancer Hospital, Anyang 455000, China
| | - X C Sun
- Department of Radiation Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
| | - K X Zhang
- Department of Oncology, Tengzhou Central People's Hospital, Tengzhou 277599, China
| | - L Li
- Department of Oncology, Tengzhou Central People's Hospital, Tengzhou 277599, China
| | - G F Li
- Department of Radiation Oncology, Beijing Hospital, National Center of Gerontology, Beijing 100730, China
| | - M L Liu
- Department of Radiation Oncology, Affiliated Hospital of Hebei University, Baoding 071000, China
| | - Y D Wang
- Department of Radiation Oncology, the Seventh Medical Center of PLA General Hospital, Beijing 100700, China
| |
Collapse
|
8
|
Yang AS, Quan GL, Gao YG, Wang J, Sui P, Li GF, Long DF, Lin SL, Wu XF, Luo B. Rectal Temperature of Corpse and Estimation of Postmortem Interval. Fa Yi Xue Za Zhi 2019; 35:726-732. [PMID: 31970962 DOI: 10.12116/j.issn.1004-5619.2019.06.015] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 04/15/2018] [Indexed: 11/30/2022]
Abstract
Abstract Measurement of corpse temperature is mainly used for estimation of early postmortem interval, and rectal temperature is often used as a representative of body's core temperature in actual work because it is simple, quick and non-invasive. At present, the rectal temperature postmortem interval estimation method internationally accepted and widely used is HENSSGE's nomogram method, while many domestic scholars also deduced their own regression equations through a large number of case data. Estimation of postmortem interval based on rectal temperature still needs further study. The nomogram method needs to be optimized and extended, and quantification of its influencing factors needs to be dealt with more scientifically. There is still a lack of consensus on the probability and duration of the temperature plateau. There is no clear understanding of the probability and extent of the change in initial temperature caused by various causes. New methods and ideas enrich methodological research, but it still lacks systemicity and practicality. This article reviews the researches on estimation of postmortem interval based on rectal temperature in order to summarize the current situation of previous researches and seek new breakthrough points. Because the decline of body temperature can be easily influenced by many factors in vitro and vivo, and the influencing factors in different regions vary greatly, regionalization research and application may be a practical exploration to improve the accuracy of postmortem interval determination.
Collapse
Affiliation(s)
- A S Yang
- Haizhu Branch of Guangzhou Public Security Bureau, Guangzhou 510290, China.,Department of Forensic Medicine, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China
| | - G L Quan
- Haizhu Branch of Guangzhou Public Security Bureau, Guangzhou 510290, China
| | - Y G Gao
- Haizhu Branch of Guangzhou Public Security Bureau, Guangzhou 510290, China
| | - J Wang
- Haizhu Branch of Guangzhou Public Security Bureau, Guangzhou 510290, China
| | - P Sui
- Haizhu Branch of Guangzhou Public Security Bureau, Guangzhou 510290, China
| | - G F Li
- Haizhu Branch of Guangzhou Public Security Bureau, Guangzhou 510290, China
| | - D F Long
- Haizhu Branch of Guangzhou Public Security Bureau, Guangzhou 510290, China
| | - S L Lin
- Haizhu Branch of Guangzhou Public Security Bureau, Guangzhou 510290, China
| | - X F Wu
- Haizhu Branch of Guangzhou Public Security Bureau, Guangzhou 510290, China
| | - B Luo
- Department of Forensic Medicine, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China
| |
Collapse
|
9
|
Shen Y, Li H, Yuan ZQ, Ren MY, Yu SL, Liao YD, Cai JJ, Liu C, Chen BC, Wu AH, Li GF, Xie L. Low pretreatment PNI correlates with worse survival in patients with stage III/IV NSCLC who received chemotherapy. Neoplasma 2019; 67:394-401. [PMID: 31847525 DOI: 10.4149/neo_2019_190401n284] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2019] [Accepted: 07/16/2019] [Indexed: 11/08/2022]
Abstract
The aim of this study was to investigate the prognostic value of the prognostic nutritional index (PNI) on the long-term survival of non-small cell lung cancer (NSCLC) patients who received platinum-based chemotherapy. Data on nutritional parameters and clinicopathological characteristics [e.g., albumin, total protein, body mass index (BMI), eastern cooperative oncology group (ECOG) performance status, stage, pathology, treatment strategy] were analyzed and retrospectively correlated with overall survival (OS). The PNI was calculated based on the concentration of albumin and lymphocyte count [10 × albumin, (g/dl) + 0.005 × lymphocyte (count/mm3)]. A receiver operating characteristic curve (ROC) analysis was used to find the optimal cut-off value of PNI. Univariate and multivariate analyses were used to evaluate the prognostic value of PNI. A total of 186 patients met the inclusion criteria. The optimal cut-off value for PNI was 50.45. Compared with the parameters of the low PNI group (n=76), high PNI was significantly associated with adenocarcinoma type, stage III, better ECOG and comprehensive treatment modality. The univariate analysis demonstrated that OS was superior when PNI ≥50.45, albumin ≥35 g/l, platelet-lymphocyte ratio (PLR) ≥163 and ECOG <2, and when the patient received a comprehensive treatment modality. In the multivariate analysis, PNI, TNM stage and treatment strategy were identified as independent predictors of survival in this study. This retrospective study demonstrated that a low PNI was related to worse overall survival in patients with stage III/IV NSCLC who received platinum-based chemotherapy. These data provided a conceptual basis for further research on the clinical application of the PNI index for patients receiving chemotherapy for intermediate- and advanced-stage NSCLC.
Collapse
Affiliation(s)
- Y Shen
- Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital, Yunnan Cancer Center), Kunming Medical University, Kunming, China
| | - H Li
- Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital, Yunnan Cancer Center), Kunming Medical University, Kunming, China
| | - Z Q Yuan
- Department of Internal Medicine, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital, Yunnan Cancer Center), Kunming Medical University, Kunming, China
| | - M Y Ren
- Department of Radiology, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital, Yunnan Cancer Center), Kunming Medical University, Kunming, China
| | - S L Yu
- Department of Internal Medicine, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital, Yunnan Cancer Center), Kunming Medical University, Kunming, China
| | - Y D Liao
- Department of Internal Medicine, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital, Yunnan Cancer Center), Kunming Medical University, Kunming, China
| | - J J Cai
- The Key Laboratory of Lung Cancer Research of Yunnan Province, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital, Yunnan Cancer Center), Kunming Medical University, Kunming, China
| | - C Liu
- Department of Nuclear Medicine, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital, Yunnan Cancer Center), Kunming Medical University, Kunming, China
| | - B C Chen
- Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital, Yunnan Cancer Center), Kunming Medical University, Kunming, China
| | - A H Wu
- Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital, Yunnan Cancer Center), Kunming Medical University, Kunming, China
| | - G F Li
- Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital, Yunnan Cancer Center), Kunming Medical University, Kunming, China
| | - L Xie
- Department of Internal Medicine, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital, Yunnan Cancer Center), Kunming Medical University, Kunming, China
| |
Collapse
|
10
|
Zhi CX, Liu XY, Pan HW, Li GF, Li ZH, Zhao YZ, Li HB, Guo XY, Yao SQ. [Association between dust exposure and the risk of hypertension of male coal miners in Henan Province]. Zhonghua Yu Fang Yi Xue Za Zhi 2019; 53:597-602. [PMID: 31177757 DOI: 10.3760/cma.j.issn.0253-9624.2019.06.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To explore the association between dust exposure and the incidence of hypertension in male coal miners. Methods: Using the method of retrospective cohort study,a hypertension cohort of colliery in Henan Province was established in January 2006. From 2006 to 2017,all the male coal miners in a colliery who were exposed to dust were selected into the exposure group including tunneling, mining,auxiliary and combining workers, and workers from administrative logistics departments who were not exposed to dust were selected into the control group. The eligible participants should satisfy following conditions: working more than one year, with clear and complete record of occupation change, and with complete archives and reliable diagnosis of occupational health surveillance. The exclusion criteria of participants were with hypertension at the baseline of study or with heart,liver,kidney diseases and malignant tumors. A total of 12 647 participants were enrolled in this study (11 663 in the exposure group and 984 in the control group). The follow-up period was from January 2006 to December 2017,with a total follow-up of 89 259.75 person-years. Questionnaires and physical measurements were used to collect general demographic characteristics, occupational exposure history and occupational health surveillance data of all participants. The Cox proportional hazards regression model was used to estimate the association between the dust exposure and the incidence of hypertension. Results: During the follow-up period, 2 549 new-onset hypertension patients were identified with an incidence density of hypertension about 2 855.71 per 100 000 person-years. The incidence density of hypertension was 2 967.58 per 100 000 person-years in the exposure group, and 1 643.85 per 100 000 person-years in the control group. The results of multivariate Cox proportional hazards regression model showed that after the adjustment of marriage, age, smoking, alcohol drinking and body mass index,the risk of hypertension was higher in the exposure group compared with the control group (HR=1.692, 95%CI: 1.410-2.032). Further analysis showed that compared with workers from administrative logistics departments,the risk of hypertension in tunneling,mining and auxiliary working was 1.629(1.345-1.973),1.677(1.374-2.046) and 1.782(1.475-2.151),respectively. Conclusion: Dust exposure may increase the risk of hypertension in male coal miners.
Collapse
Affiliation(s)
- C X Zhi
- School of Public Health, Xinxiang Medical University, Xinxiang 453003, China
| | - X Y Liu
- School of Public Health, Xinxiang Medical University, Xinxiang 453003, China
| | - H W Pan
- China Pingmei Shenma Group of Institute of Occupational Health, Pingdingshan 462500, China
| | - G F Li
- China Pingmei Shenma Group of Institute of Occupational Health, Pingdingshan 462500, China
| | - Z H Li
- School of Public Health, Xinxiang Medical University, Xinxiang 453003, China
| | - Y Z Zhao
- School of Public Health, Xinxiang Medical University, Xinxiang 453003, China
| | - H B Li
- School of Public Health, Xinxiang Medical University, Xinxiang 453003, China
| | - X Y Guo
- China Pingmei Shenma Group of Institute of Occupational Health, Pingdingshan 462500, China
| | - S Q Yao
- School of Public Health, Xinxiang Medical University, Xinxiang 453003, China
| |
Collapse
|
11
|
Hu B, Kou ZQ, Shao CC, Yin HY, Liu ZD, Xu XH, Fang M, Chen BL, Wei CY, Li GF, Bi ZW. [Characteristics and drug resistance of non-O157 Shiga toxin-producing E. coli in animal feces, from Shandong Province]. Zhonghua Yu Fang Yi Xue Za Zhi 2019; 52:271-276. [PMID: 29973006 DOI: 10.3760/cma.j.issn.0253-9624.2018.03.010] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To understand the infection status, characteristics and drug resistance of non-O157 Shiga toxin-producing E. coli (STEC) in animal feces in Shandong Province. Methods: From 2015 to 2016, convient sampling method was used to collect 1 022 fresh feces of animals in Weishan county and Laizhou city, and 24 non-O157 STEC were isolated. The serotypes of non-O157 STEC strains were confirmed through serum agglutination test. The susceptibility was explored through the antimicrobial sensitivity experiments. ESBLs activity was confirmed by double-disc diffusion. PCR method was used to detect the resistance genes. PFGE typing was operated to assess the relatedness and variability of the strains. The multi-locus sequence typing (MLST) was adopted to get the allelic profile and ST sequence of strains. Analysis was made on the evolutionary relationship between different ST groups was made through CLC Sequence Viewer and Counting Express. Results: A total of 24 non-O157 STEC were isolated from animal feces. 23 strains were from pig feces, and 1 strain was from cow feces, and the serotypes were more dispersed. All of the 24 strains carried stx2 genes. The highest resistance rate was sulfamethoxazole(22 strains), the mount of cotrimoxazole and nalidixic acid was 18 strains, chloramphenicol was 13 strains, tetracycline was 19, and there was a phenomenon of multiple drug resistance. The drug resistance spectrum was sulfamethoxazole tetracycline-compound novammin-naphthidine-chloramphenicol. All strains were sensitive to cefepime and imipenem. The ESBLs confirmatory test showed that 4 strains of non O157 STEC produced beta lactamase. PCR detected 7 resistance genes, and 4 tetracycline resistance genes (Tet A, Tet B, tetC and tetD) were detected. The beta lactamase resistance genes (blaSHV-1, bla CTX-M, bla TEM) were all negative. 24 strains were divided into 15 PFGE types, and their clustering results were more dispersed and no dominant PFGE type. There were 11 kinds of MLST types, most of them are ST540 and ST5133 types, each of which was 4 strains, and clustered into 1 MLST genomes. Conclusion: The serotypes of non-O157 STEC in animal feces O157 STEC were dispersed, and the resistant rate to common antibiotic was high. MLST typing results presents obvious polymorphism. Surveillance and manage ment of these strains should be strengthened.
Collapse
Affiliation(s)
- B Hu
- Shandong Provincial Center for Disease Control and Prevention, Ji'nan, Shandong 250014, China
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Li GF, Cheng YY, Li BJ, Zhang C, Zhang XX, Su J, Wang C, Chang L, Zhang DZ, Tan CL, Wang N. miR-375 inhibits the proliferation and invasion of glioblastoma by regulating Wnt5a. Neoplasma 2019; 66:350-356. [PMID: 30784283 DOI: 10.4149/neo_2018_180714n484] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2018] [Accepted: 11/06/2018] [Indexed: 11/08/2022]
Abstract
The aberrant expression of microRNA-375 (miR-375) has been proved to be associated with carcinogenesis. However, the role of miR-375 in glioblastoma (GBM) remains unknown. The aim of this study was to investigate biological functions and its molecular mechanisms of miR-375 in GBM cells. In this study, real-time PCR results showed that the level of miR-375 expression in GBM tissues and GBM cell lines (U87 and U251) was decreased. Using MTT assay, Transwell migration and invasion assay, we demonstrated that miR-375 overexpression significantly suppress cell proliferation, cell migration and cell invasion capacity in U87 and U251 cells. However, downregulation of miR-375 had reverse effects on cell proliferation, migration and invasion. Targeting association analysis, dual luciferase assay, RT-PCR and western blot analysis results confirmed that miR-375 could target the 3'UTR of Wnt5a mRNA and regulated its protein expression. Further studies also find overexpression of Wnt5a could significantly reverse miR-375-mediated proliferation, migration and invasion on U87 and U251 cells. Therefore, we concluded that miR-375 inhibited the proliferation and invasion of GBM by regulating Wnt5a and might be a possible therapeutic agent for GBM.
Collapse
Affiliation(s)
- G F Li
- Department of Neurosurgery, Cancer Hospital, Harbin Medical University, Harbin, China
| | - Y Y Cheng
- Department of Ultrasound, Cancer Hospital, Harbin Medical University, Harbin, China
| | - B J Li
- Department of Head and Neck Surgery, Cancer Hospital, Harbin Medical University, Harbin, China
| | - C Zhang
- Department of Ultrasound, Cancer Hospital, Harbin Medical University, Harbin, China
| | - X X Zhang
- Department of Neurosurgery, Cancer Hospital, Harbin Medical University, Harbin, China
| | - J Su
- Department of Neurosurgery, Cancer Hospital, Harbin Medical University, Harbin, China
| | - C Wang
- Department of Neurosurgery, Cancer Hospital, Harbin Medical University, Harbin, China
| | - L Chang
- Department of Neurosurgery, Cancer Hospital, Harbin Medical University, Harbin, China
| | - D Z Zhang
- Department of Neurosurgery, Cancer Hospital, Harbin Medical University, Harbin, China
| | - C L Tan
- Department of Neurosurgery, Cancer Hospital, Harbin Medical University, Harbin, China
| | - N Wang
- Department of Neurosurgery, The First Clinical Hospital affiliated to Harbin Medical University, Harbin, China
| |
Collapse
|
13
|
Chen GT, Han N, Li GF, Li X, Li G, Liu YZ, Wu W, Wang Y, Chen YX, Sun GX, Li ZC, Li QC. TNF-α mutation affects the gene expression profiles of patients with multiple trauma. EUR J INFLAMM 2015. [DOI: 10.1177/1721727x15588433] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023] Open
Abstract
Multiple trauma can induce sepsis and organ failure, even threaten people’s lives. To further study the mechanisms of multiple trauma, we analyzed microarray of GSE5760. GSE5760 was downloaded from the Gene Expression Omnibus including a total of 58 peripheral blood transcriptome from patients without (WT, n = 30) and carrying (MUT, n = 28) the tumor necrosis factor (TNF) rs1800629 A variant. The differentially expressed genes (DEGs) were screened using the limma package in R and the Benjamin and Hochberg method in a multi-test package. Then, functional enrichment analysis of DEGs was performed. Also, transcription factors significantly related to DEGs were searched using WebGestalt and interaction network of transcription factors and DEGs were constructed using STRING online software. Furthermore, pathway enrichment analysis for the DEGs in the interaction network was conducted using KO-Based Annotation System (KOBAS). We screened 39 DEGs including 27 upregulated and 12 downregulated genes. The enriched functions were associated with biological process (BP) (such as response to hypoxia, P value = 0.039803), cell components (CC) (such as mitochondrial part, P value = 0.043857), and molecular function (MF) (such as structural constituent of ribosome, P value = 0.008735). Besides, RPS7 and RPL17 were associated with ribosome and participated in ribosome pathway. PPP2R2B was related to mitochondrion. KCNMA1, ALAS2 and SOCS3 were associated with hypoxia. Moreover, transcription factors of LEF1, CHX10, ELK1, SP1, and MAZ were significantly related to DEGs. RPS7, RPL17, PPP2R2B, KCNMA1, ALAS2, and SOCS3 might relate to multiple trauma. And TNF-α mutation could cause sepsis in patients with multiple trauma by changing the expression of these genes.
Collapse
Affiliation(s)
- GT Chen
- Department of Emergency Surgery, East Hospital, Tongji University School of Medicine, Shanghai, PR China
| | - N Han
- Department of Emergency Surgery, East Hospital, Tongji University School of Medicine, Shanghai, PR China
| | - GF Li
- Department of Emergency Surgery, East Hospital, Tongji University School of Medicine, Shanghai, PR China
| | - X Li
- Department of Emergency Surgery, East Hospital, Tongji University School of Medicine, Shanghai, PR China
| | - G Li
- Department of Emergency Surgery, East Hospital, Tongji University School of Medicine, Shanghai, PR China
| | - YZ Liu
- Department of Emergency Surgery, East Hospital, Tongji University School of Medicine, Shanghai, PR China
| | - W Wu
- Department of Emergency Surgery, East Hospital, Tongji University School of Medicine, Shanghai, PR China
| | - Y Wang
- Department of Emergency Surgery, East Hospital, Tongji University School of Medicine, Shanghai, PR China
| | - YX Chen
- Department of Emergency Surgery, East Hospital, Tongji University School of Medicine, Shanghai, PR China
| | - GX Sun
- Department of Emergency Surgery, East Hospital, Tongji University School of Medicine, Shanghai, PR China
| | - ZC Li
- Department of Emergency Surgery, East Hospital, Tongji University School of Medicine, Shanghai, PR China
| | - QC Li
- Department of Emergency Surgery, East Hospital, Tongji University School of Medicine, Shanghai, PR China
| |
Collapse
|
14
|
Abstract
Cherry mottle leaf virus (CMLV) is a member of the genus Trichovirus (family Betaflexiviridae). CMLV infects several species of the genus Prunus including cherry (Prunus avium) and peach (P. persica) (2,3). It is spread via budding and grafting with infected wood and can be transmitted from infected bitter cherry (P. emarginata), or infected but symptomless peach trees to healthy sweet cherry trees by the bud mite (Eriophyes inaequalis) (1). On susceptible sweet cherry cultivars, CMLV causes symptoms such as chlorotic mottle-leaf pattern, distortion, puckering of younger leaves, and small fruits that ripen late (1), which may lead to severe economic losses in some cultivars. Cherry is one of the most important fruit tree species in North China, and Shandong Province is one of the major cherry production areas. In June 2013, a survey of possible CMLV presence was conducted in a cherry orchard planted in 1996 in Zoucheng city, Shandong. The sweet cherry cultivars in this orchard included Black Tartarian, Bing, Hongdeng (a hybrid between cvs. Napoleon and Huangyu), and others; the rootstock cultivar utilized to graft these cultivars was mountain cherry (P. tomentosa). During the survey, characteristic symptoms on leaves such as leaf mottling, distortion, and puckering similar to those caused by CMLV were observed on some trees of the cv. Hongdeng, and the symptomatic trees accounted for ~10% of the total trees of this cultivar. Five symptomatic cherry leaf samples and three healthy-looking cherry leaf samples of cv. Hongdeng were collected. Total RNA extracted from the leaf samples using RNeasy plant mini kit (Qiagen Inc., Valencia, CA) was subjected to first strand cDNA synthesis with the reverse primer CMLV-3R (5'-CTCGAGAACACAGAGATTTGTCGAGAC-3', sequence in italics indicates restriction site XhoI) and M-MLV reverse transcriptase (Promega, Madison, WI) according to the manufacturer's instruction. The cDNA was then used as template in the PCR assay using primers CMLV-5F (5'-GGATCCATGTCGGCGCGATTGAATC-3', sequence in italics indicates restriction site BamHI) and CMLV-3R, which amplify the genome fragment including the capsid protein gene of CMLV. The expected PCR product ~590 bp was amplified from all five symptomatic samples, while no such PCR product was amplified from the symptomless samples. The PCR products were cloned into pMD18-T vector (TaKaRa, Dalian, China). Three positive clones for each of the five amplicons were sequenced in both directions. Sequence alignment and nucleotide BLAST analysis of the sequences revealed that they were 99% to 100% identical to the corresponding capsid protein gene sequence of a cherry isolate of CMLV (GenBank Accession No. AF170028) and 85% identical with that of the peach wart strain of CMLV (KC207480). Our results confirm the infection of cherry trees by CMLV in Shandong. To our knowledge, this is the first report of CMLV on cherry in China. As the spread of CMLV by mite vector in the field is rare (1), and no bud mite outbreak had occurred in this orchard in the past years, so it is possible that virus-infected propagation materials are largely responsible for the spread of this virus. Considering the importance of cherry cultivation in China, this report prompts the need to survey the occurrence of this virus in Shandong and other provinces, and the need to develop more effective management strategies such as the use of certified virus-free nursery stocks to reduce the impact of CMLV. References: (1) J. E. Adaskaveg et al. Diseases. Page 61 in: UC IPM Pest Management Guidelines: Cherry. University of California ANR Publication 3444, 2014. (2) D. James et al. Arch. Virol. 145:995, 2000. (3) T. A. Mekuria et al. Arch. Virol. 158:2201, 2013.
Collapse
Affiliation(s)
- Y X Ma
- Institute of Plant Quarantine, Chinese Academy of Inspection and Quarantine, Beijing 100029, P. R. China
| | - J J Li
- Department of Plant Pathology, College of Plant Protection, Shandong Agricultural University, Tai'an 271018, Shandong, P. R. China
| | - G F Li
- Institute of Plant Quarantine, Chinese Academy of Inspection and Quarantine, Beijing 100029, P. R. China
| | - S F Zhu
- Institute of Plant Quarantine, Chinese Academy of Inspection and Quarantine, Beijing 100029, P. R. China
| |
Collapse
|
15
|
Wei MS, Zhang YJ, Li GF, Ma J, Li M. First Report of Hosta virus X Infecting Hosta Plants in China. Plant Dis 2013; 97:429. [PMID: 30722388 DOI: 10.1094/pdis-09-12-0810-pdn] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Hosta (Hosta spp.) plants showing leaf deformation, puckering, and ink-bleed symptoms were collected in July 2012 from a park at Dongcheng district, Beijing, China. Three out of six samples tested positive for Hosta virus X (HVX) by immunostrip and double-antibody sandwich (DAS)-ELISA with HVX-specific serological reagents from Agdia Inc. (Elkhart, IN, USA). Filamentous viral particles were trapped and observed from the infected hosta leaf sap by immuno-serological electron microscopy (ISEM) (antibodies from Agdia). To confirm HVX infection, three ELISA-positive samples were analyzed by reverse transcription-PCR assay, using virus-specific primers HVXf (5'-ATCCGTTATCTACAGGGGACCAG-3') and HVXr (5'-TAAGTTAGTGGAACGGTTAGCCCGAT-3') that amplified a 1,067-bp fragment including the coat protein (CP) coding region. The CP nucleotide sequence comparisons showed 99% to 100% homology among the three isolates named HVXBJ4, HVXBJ5, and HVXBJ6 (GenBank Accession No. JX535292, JX535293, and JX535294) and with the HVX sequences previously reported in GenBank. HVX has been reported from the United States, Korea, the Netherlands, Poland, France, the Czech Republic, and New Zealand (1,2). To our knowledge, this is the first report of HVX infecting hosta plants in China. As an ornamental and medicinal plant, hosta has been cultivated in China for more than 2,000 years. The presence of HVX in Beijing is a potential threat to the landscape in the city. HVX can be spread by vegetative propagation material or mechanical contact (3). Hence, to cultivate HVX-free hosta and restrict the movement of HVX-infected hosta is vitally important in the future. HVX has become economically important in the world more recently. Globalization of trade in hosta plants has increased the risk of movement of HVX. The national plant protection organization should establish effective quarantine strategy and the growers take proper planting measures to avoid further spreading of this virus. References: (1) S. Currier et al. Plant Dis. 80:1040, 1996. (2) M. H. Park et al. Arch. Virol. 148:2039, 2003. (3) K. H. Ryu et al. Acta Hortic. 722:91, 2006.
Collapse
Affiliation(s)
- M S Wei
- Institute of Plant Quarantine, Chinese Academy of Inspection and Quarantine, Beijing, 100029, China
| | - Y J Zhang
- Institute of Plant Quarantine, Chinese Academy of Inspection and Quarantine, Beijing, 100029, China
| | - G F Li
- Institute of Plant Quarantine, Chinese Academy of Inspection and Quarantine, Beijing, 100029, China
| | - J Ma
- Institute of Plant Quarantine, Chinese Academy of Inspection and Quarantine, Beijing, 100029, China
| | - M Li
- Institute of Plant Quarantine, Chinese Academy of Inspection and Quarantine, Beijing, 100029, China
| |
Collapse
|
16
|
Abstract
Osteoporosis has until now been considered to be a disease associated with abnormal calcium metabolism. However, an increasing number of clinical observations strongly suggest the association of iron overload with bone diseases, particularly in osteoporosis in menopausal women. The recent identification of hepcidin sheds new light into the crucial role of iron homeostasis in bone metabolism. Decreasing iron overload in cell studies as well as in animal experiments has been shown to improve bone cell metabolism and growth in vitro and in vivo. In view of the significant iron overload found in the aging population, especially in females, the therapeutic potential of lowering iron overload for the treatment of osteoporosis is suggested.
Collapse
Affiliation(s)
- G F Li
- Department of Orthopaedics, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
| | | | | | | | | |
Collapse
|
17
|
Li GF, Wei MS, Ma J, Zhu SF. First Report of Broad bean wilt virus 2 in Echinacea purpurea in China. Plant Dis 2012; 96:1232. [PMID: 30727089 DOI: 10.1094/pdis-04-12-0409-pdn] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Field-grown Echinacea purpurea plants showing necrosis, leaf roll, yellow mosaic, and mosaic symptoms in leaves were collected in June 2010 in Huairou, Beijing, China. ELISAs of extracts of four samples showed that one sample with mosaic symptoms had a positive reaction with Broad bean wilt virus 2 (BBWV-2) monoclonal antibody provided by Professor X. P. Zhou (1). The monoclonal antibody recognized the 44.7 kD coat protein subunit of BBWV-2. We used Chenopodium quinoa as an assay species to isolate the virus by sap transmissions and to maintain the virus strain. Sap from infected C. quinoa, when inoculated onto indicator plant species, induced the following symptoms: C. quinoa: local lesions in inoculated leaves, systemic chlorotic mottle in upper leaves, deformation, and apical necrosis; C. amaranticolor: chlorotic local lesions, systemic mosaic and leaf distortion; Nicotiana benthamiana: systemic mosaic; Gomphrena globosa: local purple spots in inoculated leaves and systemic infection in upper leaves; Tetragonia expansa: local lesions, but no symptoms of systemic infection; Physalis floridana: systemic mosaic. No symptoms were observed on Capsicum annuum, Datura stramonium, N. glutinosa, or N. tabacum cv. White Burley. To confirm BBWV-2 infection, total RNAs extracted from infected C. quinoa leaves were reverse transcripted to cDNA using oligo-dT primer (T17V). The primer pair Fab5'R1F (5'-AAATATTAAAACAAACAGCTTTCGTT-3') and Fab5'R1R (5'-TTCAAAGCTCGTGCCATNTYATTKGC-3') for specific detection of the Fabavirus genus (2) was used for PCR analysis. The amplified fragment is between the 5'-terminal non-translatable region (NTR) and the beginning of the coding region of RNA1. Amplicons of approximately the expected size (~391 bp) were produced from the virus-infected C. quinoa and a BBWV-2 positive control (ATCC PV131, PV0537). Amplicons of approximately the expected size (~350 bp) were produced from the BBWV-1 positive control (ATCC PV132). However, no such amplicons were observed from healthy C. quinoa plants and water control. The 391-bp amplicons of RNA1 obtained from the infected C. quinoa were cloned and sequenced. Comparison with sequences of other BBWV-2 isolates showed that the isolate we obtained (No. JX070674) had approximately 99% nt identity (98% amino acid identity) with Chinese BBWV-2 isolate BC (No. FJ485686.1) (3). As an ornamental and medicinal plant, E. purpurea is widely cultivated in northern China. Up until now, Tomato ring spot virus, Tobacco rattle virus, Cucumber mosaic virus, and Tomato spotted wilt virus have been detected or isolated from E. purpurea in the world (4). To our knowledge, this is the first report of BBWV-2 infecting E. purpurea in China. BBWV-2-infected E. purpurea may have less secondary metabolites, which could influence the quality and therapeutic efficacy of this herbal medicine. References: (1) L. Qing et al. Acta Microbiologica Sinica 40:166, 2000. (2) R. M. Ferrer et al. J. Virol. Methods 144:156, 2007. (3) C. Sui et al. Plant Dis. 93:844, 2009. (4) B. Dikova. Bulgarian J. Agric. Sci. 17:306, 2011.
Collapse
Affiliation(s)
- G F Li
- Institute of Plant Quarantine, Chinese Academy of Inspection and Quarantine, Beijing, 100029, China
| | - M S Wei
- Institute of Plant Quarantine, Chinese Academy of Inspection and Quarantine, Beijing, 100029, China
| | - J Ma
- Institute of Plant Quarantine, Chinese Academy of Inspection and Quarantine, Beijing, 100029, China
| | - S F Zhu
- Institute of Plant Quarantine, Chinese Academy of Inspection and Quarantine, Beijing, 100029, China
| |
Collapse
|
18
|
Wang CX, Li BH, Dong XL, Li GF. First Report of Stem Canker on Cherry Caused by Phomopsis perniciosa in Shandong Peninsula, Eastern China. Plant Dis 2011; 95:1316. [PMID: 30731669 DOI: 10.1094/pdis-04-11-0341] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Cherry is a main fruit tree species in Shandong Peninsula, which is one of the most important cherry-production areas of China. A stem canker disease was first noted in a 15-year-old cherry orchard in Yantai, Shandong Peninsula in May 2009. Canker and branch dieback were the main symptoms of the disease and cracks often appeared at the margins of sunken cankers, which exposed the wooden stem. In later stages from April to May, black pycnidia were observed on the surface of cankered bark and cirri containing α-conidia were extruded under wet conditions. Wooden tissue under the diseased bark was dark brown, in contrast to the healthy tissue that was yellowish green. On the basis of morphological characteristics, the pathogen was putatively identified as Phomopsis perniciosa (1). Pycnidia were smaller in naturally infected branches than when produced on potato dextrose agar (PDA) medium (180 to 365 × 65 to 226 μm). Cultures of the pathogen appeared creamy white with concentric rings on PDA at 25°C and a mass of α-conidia (5.75 to 11.13 × 2.08 to 3.46 μm) and β-conidia (31.24 to 34.68 × 1.45 to 1.82 μm) were produced within 3 weeks. Alpha-conidia were hyaline, fusiform-elliptic to oblong-elliptic, and biguttulate. Beta-conidia were hyaline and unicellular, filiformia, leviter arcuata vel hamata. Total DNA was extracted from three monoconidial isolates collected from different infected trees. The internal transcribed spacer (ITS) region was amplified using the universal primers ITS1 (5'-TCCGTAGGTGAACCTGCGG-3') and ITS4 (5'-CCTCCGCTTATTGATATGC-3'). The ITS amplicons were sequenced (582 bp) from three isolates and no nucleotide variation was observed. BLAST analysis of the obtained ITS sequences showed that isolate 230101 had 99% homology with a Phomopsis sp. (GenBank Accession No. AB302248) isolated from fruit trees in Japan. The nucleotide sequence from isolate 230101 has been deposited in GenBank (Accession No. JF812647). Pathogenicity of the isolate was confirmed by inoculating branches of 3-year-old cherry trees with either conidia or hyphae. Inoculations were performed by making an incision with a sterile scalpel at the dissected area to expose the tissue under the bark. An agar plug (4 × 4 mm) containing 5-day-old cultured hyphae or 50 μl of a conidium suspension containing 106 α-conidia per ml was placed on each of the inoculation sites, wrapped with moist cheesecloth, and sealed with Parafilm. Control trees were treated similarly with sterile blocks of PDA or water, respectively. For each inoculation technique, five shoots were inoculated and the inoculation treatments were replicated three times. All inoculated and control trees were kept in a greenhouse and watered as needed. After 10 days, cankers and necrotic lesions developed on all shoots inoculated with P. perniciosa and the control trees did not display any symptoms. The same pathogen was reisolated from symptomatic branches. Phomopsis spp. are known to cause cankers and dieback of several woody hosts (2), but no reports have been found that the pathogen causes cherry canker and dieback in China. References: (1) P. K. Chi et al. Flora Fungorum Sinicorum-Phomopsis 34:127, 2007. (2) D. P. Weingartner and E. J. Klos. Phytopathology 65:105, 1975.
Collapse
Affiliation(s)
- C X Wang
- College of Agronomy and Plant Protection, Qingdao Agricultural University, Qingdao, Shandong 266109, China
| | - B H Li
- College of Agronomy and Plant Protection, Qingdao Agricultural University, Qingdao, Shandong 266109, China
| | - X L Dong
- College of Agronomy and Plant Protection, Qingdao Agricultural University, Qingdao, Shandong 266109, China
| | - G F Li
- College of Agronomy and Plant Protection, Qingdao Agricultural University, Qingdao, Shandong 266109, China
| |
Collapse
|
19
|
Abstract
Cucumber green mottle mosaic virus (CGMMV) was first discovered in 2003 in China (2) and developed an epidemic during 2005 (1). To know the occurrence scale and damage level of CGMMV, a survey was carried out in the main areas of cucurbitaceous plant production and seed trading in 2006 and 2007 in Mainland China. Samples of 739 plants of 16 types (seed samples from Cucurbita moschata, Cucumis melo, Lagenaria siceraria, Cucumis sativus, Momordica charantia, L. siceraria var. clavata, and C. pepo, leaf samples from C. moschata, Cucumis melo, L. siceraria, Cucumis sativus, and M. charantia, fruit samples from C. moschata, Citrullus lanatus, and L. siceraria, and seedling samples from Citrullus lanatus) were collected from 13 regions and analyzed by a double antibody sandwich (DAS)-ELISA. CGMMV was detected in Citrullus lanatus, L. siceraria, Cucumis melo, and C. moschata from six regions in 2006. Citrullus vulgaris, Cucumis melo, and C. moschata were infected most frequently; in 76, 60, and 30 of the leaf samples, respectively. CGMMV was tested positive in the samples of 8 seedlings, 23 seeds, and 1 fruit. In contrast, all samples tested negative in 2007. To confirm CGMMV identification, ELISA-positive samples were detected by reverse transcription-PCR assay using virus-specific primers that amplified a 524-bp fragment in the coat protein coding region. The nucleotide sequence of the PCR product (GenBank Accession No. DQ997778) isolated form L. siceraria in Liaoning Province (LHP) showed 100% identity with the Japanese watermelon strain (Japan W) and 91% identity with the Greece GR5 strain. On the basis of the symptoms of indicator plants (chlorotic spot and systemic mosaic were observed in L. siceraria, Chenopodium amaranticolor, and Cucumis sativus; no infection was observed in Datura stramonium, Nicotiana tabacum, and Chenopodium quinoa) and coat protein nucleotide sequence comparisons, the two CGMMV isolates of Wcn (1) and LHP from China should be grouped into the watermelon strain. The results showed that the government should establish effective quarantine strategy and the growers take proper planting measures to avoid further spreading of this virus. References: (1) H. Y. Chen et al. Acta Phytopathol. Sin. 36:306, 2006. (2) B. X. Qin et al. Plant Quarantine. 19:4, 2005.
Collapse
Affiliation(s)
- Y J Zhang
- Chinese Academy of Inspection and Quarantine, Beijing 100029, China
| | - G F Li
- Chinese Academy of Inspection and Quarantine, Beijing 100029, China
| | - M F Li
- Chinese Academy of Inspection and Quarantine, Beijing 100029, China
| |
Collapse
|
20
|
Wang H, Liu Y, Chong K, Liu BY, Ye HC, Li ZQ, Yan F, Li GF. Earlier flowering induced by over-expression of CO gene does not accompany increase of artemisinin biosynthesis in Artemisia annua. Plant Biol (Stuttg) 2007; 9:442-6. [PMID: 17099845 DOI: 10.1055/s-2006-924634] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
Abstract
The early flowering gene CONSTANS (CO) from Arabidopsis thaliana was transferred into Artemisia annua using the Agrobacterium tumefaciens-mediated transformation system. The plant expression vector pBI CO was constructed by inserting the CO gene into the binary vector pBI121 under the control of CaMV 35S promoter. Analyses of PCR, PCR Southern blot, and Southern blot revealed that the transgenic plants contained the foreign CO gene. The results of RT-PCT and RT-PCR Southern blot suggested that the foreign CO gene had expressed at the transcriptional level. Although the flowering time of the CO transgenic plant was about 2 weeks earlier than that of the non-transgenic plant under short-day conditions, no significant difference in artemisinin content was found between the flowering transgenic plant and the non-flowering non-transgenic plant. These results show that the usually observed increase of artemisinin content before plant flowering under natural conditions is not a direct consequence of flowering itself, perhaps there is even no direct linkage between flowering and artemisinin biosynthesis.
Collapse
Affiliation(s)
- H Wang
- Key Laboratory of Phytosynthesis and Environmental Molecular Physiology, Institute of Botany, The Chinese Academy of Sciences, Nanxincun 20#, Xiangshan, Haidian District, Beijing 100093, China
| | | | | | | | | | | | | | | |
Collapse
|
21
|
Sun ZW, Shan CQ, Li GF, Ding DB, Liu GY, Wang JY, Jiao XQ. [Clinical comparative trial of co-artemether and benflumetol (two formulations) in the treatment of falciparum malaria]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2003; 18:159-61. [PMID: 12567694] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/28/2023]
Abstract
OBJECTIVE To observe the efficacy and safety of co-artemether and one of its components benflumetol (two formulations) in the treatment of patients with falciparum malaria. METHODS Adopting double-blining, randomization and comparative method, all patients were hospitalized and observed for 28 days after treatment. RESULTS Of 150 patients, 51 patients were treated with co-artemether group(A), 50-patients were treated with benflumetol tablet group(B), 49 patients were freated with benflumetol capsule group(C). The mean fever clearance times for groups A, B and C were 17.1 +/- 8.6, 34.0 +/- 23.2 and 29.4 +/- 24.9 hours, respectively; the mean parasite clearance times were 29.7 +/- 8.9, 51.6 +/- 14.1 and 54.7 +/- 17.4 hours respectively; the cure rates in 28 days for groups A, B and C were 98.2%, 92.0% and 95.8%, respectively. No apparent side-effect was observed. CONCLUSION Co-artemether and benflumetol (2 formulations) are effective for the treatment of patients with falciparum malaria but co-artemether is more effective than benflumetol (2 formulations) in terms of controlling symptoms and killing parasites.
Collapse
Affiliation(s)
- Z W Sun
- Institute of Microbiology and Epidemiology, Academy of Millitary Medical Sciences, Beijing 100071
| | | | | | | | | | | | | |
Collapse
|
22
|
Xu MS, Huang LQ, Fu MH, Te HC, Li GF. [Induction of callus of Hypericum perforatum L. and qualitative identification of active constituents of its callus]. Zhongguo Zhong Yao Za Zhi 2001; 26:813-5. [PMID: 12776326] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/02/2023]
Abstract
OBJECTIVE To induce the callus of H. perforatum and identify hypericin and pseudohypericin of its callus. METHOD The callus was induced in different culture conditions, and active constituents were determined by HPLC. RESULT AND CONCLUSION The inductions of callus from different parts were discussed, the induction rate of the leaf axil being the highest. The MS basic medium with 4 micrograms.L-1 2,4-D and 0.2 microgram.L-1 6-BA was the best of all screened media. Hypericin in the callus is determined by HPLC.
Collapse
Affiliation(s)
- M S Xu
- Institute of Chinese Materia Medica, Academy of Traditional Chinese Medicine, Beijing 100700
| | | | | | | | | |
Collapse
|
23
|
Jin XL, Jin WQ, Zhou DH, Li GF, Chi ZQ. [Effects of ohmefentanyl at anesthetic dose on plasma levels of corticosterone, cortisol and antidiuretic hormone in rats]. Yao Xue Xue Bao 2001; 32:228-30. [PMID: 11327028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
Abstract
Ohmefentanyl (OMF) is a new mu opioid receptor agonist with high affinity and selectivity, and possesses anesthetic activity. With radioimmunoassay, the plasma levels of cortisol (C), corticosterone (CS) and antidiuretic hormone (ADH) in rats were measured. The results indicated that no significant differences in the plasma C, CS and ADH levels were observed between the saline control group and the OMF-treated group. Trauma (bone-crush injury) increased significantly the plasma CS level. However, pretreatment with OMF 4.0 micrograms.kg-1 reduced markedly the CS plasma levels in trauma-treated rats. The results suggest that OMF anesthesia itself showed no obvious effect on the plasma concentration of C, CS and ADH, but blocked the hormoral stress responses such as the increment of plasma CS level caused by trauma stimulus.
Collapse
Affiliation(s)
- X L Jin
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 200031
| | | | | | | | | |
Collapse
|
24
|
Ruan X, Xu Q, Mao HB, Li GF, Wei J, Gong YD, Kuang TY, Zhao NM. Strong-light photoinhibition treatment accelerates the changes of protein secondary structures in triton-treated photosystem I and photosystem II complexes. J Protein Chem 2001; 20:247-54. [PMID: 11565905 DOI: 10.1023/a:1010908210655] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Changes in the protein secondary structure and electron transport activity of the Triton X-100-treated photosystem I (PSI) and photosystem II (PSII) complexes after strong illumination treatment were studied using Fourier transform-infrared (FT-IR) spectroscopy and an oxygen electrode. Short periods of photoinhibitory treatment led to obvious decreases in the rates of PSI-mediated electron transport activity and PSII-mediated oxygen evolution in the native or Triton-treated PSI and PSII complexes. In the native PSI and PSII complexes, the protein secondary structures had little changes after the photoinhibitory treatment. However, in both Triton-treated PSI and PSII complexes, short photoinhibition times caused significant loss of alpha-helical content and increase of beta-sheet structure, similar to the conformational changes in samples of Triton-treated PSI and PSII complexes after long periods of dark incubation. Our results demonstrate that strong-light treatment to the Triton-treated PSI and PSII complexes accelerates destruction of the transmembrane structure of proteins in the two photosynthetic membranes.
Collapse
Affiliation(s)
- X Ruan
- Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing, China
| | | | | | | | | | | | | | | |
Collapse
|
25
|
Shi YL, Li GF, Zhao JH, Yang JD, Ding DB. Schizontocidal effects of oral artesunate on Plasmodium berghei in mice and P knowlesi in monkeys. Zhongguo Yao Li Xue Bao 1999; 20:755-8. [PMID: 10678113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/15/2023]
Abstract
AIM To study the blood schizontocidal effect of oral artesunate on P berghei in mice and P knowlesi in monkey. METHODS Effects of artesunate and chloroquine were detected with "4-day test" and "28-day test" on P berghei in mice and "7-day test" on P knowlesi in Macaca mudatta. RESULTS The suppressive efficacy of oral artesunate was inferior to chloroquine on P berghei K173 strain but the time for 50% and 90% reduction and the time of clearance of parasitemia was 10-15 h shorter than that of chloroquine. Its curative effect on RC/K173 line was markedly superior to that of chloroquine. Moreover, artesunate showed no cross-resistance with chloroquine, index of resistance I90 was only 1.4. At 31.6, 10.0, and 3.16 mg.kg-1, artesunate and chloroquine oral administrations cured P knowlesi in all monkeys. Recrudescence did not occur in 105 d. CONCLUSION The study of effects of oral artesunate in P berghei/mice and P knowlesi/Macaca mulatta model provided a useful index for clinical trial.
Collapse
Affiliation(s)
- Y L Shi
- Laboratory of Antimalarial Drug Research, Academy of Military Medical Sciences, Beijing, China
| | | | | | | | | |
Collapse
|
26
|
Fujii T, Yokoyama H, Li GF, Tada H. A peptide antagonist derived from platelet-derived growth factor induces histamine release from rat peritoneal mast cells. Biol Pharm Bull 1997; 20:79-81. [PMID: 9013812 DOI: 10.1248/bpb.20.79] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
A synthetic peptide (ANFLVWEIVRKKP) designed from the platelet-derived growth factor (PDGF) B-chain, which is known to act as a PDGF antagonist, induced histamine release from rat peritoneal mast cells. Maximal release by the peptide reached about 50% of the total histamine content in mast cells and half-maximal release occurred at 15 microM. The histamine release induced by the PDGF antagonist was required for the presence of Ca2+ in the medium. Treatment of kinase inhibitors (staurosporine and genistein) with mast cells before exposure to the PDGF antagonist inhibited the release to some extent, while calmodulin antagonists (W-7 and R24571) had little effect. The PDGF antagonist induced the secretion of actin from mast cells concurrently with histamine release, though it had no effect on the distribution of tubulin. These results suggest the possibility that PDGF and its agonists may stimulate and induce exocytosis of peritoneal mast cells.
Collapse
Affiliation(s)
- T Fujii
- Faculty of Textile Science and Technology, Shinshu University, Ueda, Nagano, Japan
| | | | | | | |
Collapse
|
27
|
Jia B, Zhang ST, Li GF. [Lipid peroxidation injury to red blood cells during extracorporeal circulation: mechanism and protection]. Zhonghua Yi Xue Za Zhi 1994; 74:689-91, 711. [PMID: 7866907] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
Twelve dogs were subjected to cardiopulmonary bypass with membrane oxygenator for 120 minutes. The effect of lipid peroxide injury on red blood cells was studied by measurement of plasma and erythrocyte membrane lipid peroxide, deformabioity of erythrocyte, plasma free hemoglobin, superoxide dismutase, Na(+)-K(+)-ATPase and Ca(2+)-Mg(2+)-ATPase of erythrocytes. The effect of vitamin E on red blood cells was also investigated. The findings indicated that vitamin E might protect red blood cells from lipid peroxide injury during extracorporeal circulation. The mechanism of damage effect of lipid peroxide and the protective effect of vitamin E on red blood cells were briefly discussed.
Collapse
Affiliation(s)
- B Jia
- Department of Cardiovascular Surgery, Children's Hospital, Shanghai Medical University
| | | | | |
Collapse
|
28
|
Lu YF, Li GF, Chi ZQ. Characterization and distribution of mu opioid receptors in rabbit cerebellum. Zhongguo Yao Li Xue Bao 1993; 14:489-91. [PMID: 8010044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
The binding characteristics and distributions of [3H]ohmefentanyl ([3H]OMF), [3H]etorphine, [3H] N-methyl-N-[7-(I-pyrrolidinyl)-1-oxaspiro(4,5)dec-7-yl] benzeneacetamide [3H]U-69593), and [3H] (D-penicillamine2, D-penicillamine5) enkephalin ([3H]DPDPE) in rabbit cerebellum were studied. In saturation experiment, [3H]OMF bound to a single population of sites with Kd = 2.2 +/- 1.3 nmol.L-1 and Bmax = 69 +/- 13 fmol/mg protein. The results of [3H]etorphine (Kd = 1.0 +/- 0.4 nmol.L-1 and Bmax = 16 +/- 6 fmol/mg protein) were similar to those of [3H]OMF. There were no specific bindings of [3H]U-69593 and [3H]DPDPE in rabbit cerebellar membranes. In autoradiographic study, the gray scales of specific binding for [3H]OMF, [3H]etorphine, [3H]U-69593, and [3H]DPDPE were 20.2 +/- 4.6, 8.5 +/- 2.7, 2.0 +/- 0.7, and 3.2 +/- 4.3, respectively. The gray matter of rabbit cerebellum was intensely labeled by [3H]OMF and [3H]etorphine, but not by [3H]U-69593 or [3H]DPDPE. These results suggested that the rabbit cerebellum contained mu opioid receptors.
Collapse
Affiliation(s)
- Y F Lu
- Shanghai Joint Laboratory of Life Sciences, Chinese Academy of Sciences
| | | | | |
Collapse
|
29
|
Kong WH, Li GF, Lu BZ. [Type and content of adrenoceptors in toad heart]. Sheng Li Xue Bao 1993; 45:455-61. [PMID: 8146669] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
The type and content of adrenoceptors in heart of normothermic and cold-acclimatized toad were studied by radioligand binding assay at different testing temperatures. The Bmax and Kd values of membrane from normal toad heart binding to 3H-DHA at 37 degrees C were respectively 55.11 +/- 6.22 fmol/mg protein and 2.15 +/- 0.42 nmol/L for the whole heart, 55.80 +/- 7.03 and 2.65 +/- 0.37 for sino-atrium and 54.27 +/- 3.06 and 1.84 +/- 0.14 for ventricle. While the binding to 3H-DHE was very low and nonspecific. When membrane from cold-acclimatized toad at 5-8 degrees C for 10 days was examined for its binding to 3H-DHA or 3H-DHE at 10 degrees C, the values of Bmax and Kd were as same as those of normothermic toad examined at 37 degrees C. The present results suggest that the toad heart is lacking of alpha-adrenoceptor, and the type and content of adrenoceptors are not influenced by temperature.
Collapse
Affiliation(s)
- W H Kong
- Department of Biology, Shandong University, Jinan
| | | | | |
Collapse
|
30
|
Ji GC, Li GF, Yang TE, Kong WH. [The phase-dependent response of the heart to vagal stimulation in soft-shelled turtles]. Sheng Li Xue Bao 1993; 45:439-46. [PMID: 8146667] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
Using cardiac cycle length (A-A interval) as an index, the effect of phase-coupled burst of vagal stimulation on the heart rate were investigated in 27 turtles. The negative chronotropic response depended on timing of the stimulus burst within the cardiac cycle. At first, the A-A interval was lengthened progressively and then showed a rapid decrease. The amplitude (AT) of the mean phase-response curve to right vagal stimulus in turtles treated by propranolol at normal temperature was 1484.10 +/- 213.10 ms. The minimum-to-maximum phase difference of the response curves was 804.00 +/- 210.90 ms. Both the AT and (St-A)max of the response curve varied directly with AA. In contrast, (St-A)min was not influenced by AA. Moreover, it was also found that the tau FR, AT, AA and (St-A)min in hibernant animals were all higher than those in normal ones. However, in three of the six hibernant turtles maximum positive chronotropic response could be elicited at the time when (A-A)min was elicited by vagal stimulation. The results indicated that the phase-dependent response to right vagus in turtles was similar to that in homothermal animals, but significantly different both in the amplitude of the phase-response and the latency of negative chronotropic response. Since the phase-response was abolished by atropine, not by propranolol, it was suggested that the occurrence of phase-response was due to changes of responsiveness of automatic cells to ACh released from the vagus nerve.
Collapse
Affiliation(s)
- G C Ji
- Department of Biology, Shandong University, Jinan
| | | | | | | |
Collapse
|
31
|
Yeung KS, McKeown-Eyssen GE, Li GF, Glazer E, Hay K, Child P, Gurgin V, Zhu SL, Baptista J, Aloe M, Mee D, Jazmaji V, Austin DF, Li CC, Bruce W. Comparisons of diet and biochemical characteristics of stool and urine between Chinese populations with low and high colorectal cancer rates. J Natl Cancer Inst 1991; 83:46-50. [PMID: 1984517 DOI: 10.1093/jnci/83.1.46] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
In an investigation of the roles of diet and stool biochemistry in human colorectal carcinogenesis, 24-hour food, urine, and stool samples were collected from randomly selected participants from two populations with a fourfold difference in colorectal cancer risk: Chinese in Sha Giao, People's Republic of China (low risk), and Chinese-Americans of similar ages in San Francisco County, Calif, in the United States (high risk). The findings supported the hypotheses that colorectal cancer risk is increased by the consumption of high-fat, high-protein, and low-carbohydrate diets and is associated with high levels of cholesterol in stool as well as increased daily outputs of 3-methyl-histidine and malonaldehyde in urine. However, risk does not increase with low stool bulk and low total stool fibers.
Collapse
Affiliation(s)
- K S Yeung
- Ludwig Institute for Cancer Research, Toronto, ON, Canada
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Wang H, Ye SZ, Li GF, Chi ZQ. [Comparison of ontogenies of opioid receptors in rat, guinea pig and rabbit CNS by autoradiography]. Zhongguo Yao Li Xue Bao 1988; 9:205-12. [PMID: 2850708] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
|
33
|
Yao YH, Xu H, Li GF, Chi ZQ. [Autoradiographic distribution of [3H]ohmefentanyl binding sites in rat corpus striatum]. Zhongguo Yao Li Xue Bao 1988; 9:212-5. [PMID: 2850709] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
|
34
|
Liu DX, Lin ZJ, Li GF, Gao XK. [Studies on the adhesion of Campylobacter jejuni/coli to HeLa cells]. Hua Xi Yi Ke Da Xue Xue Bao 1987; 18:335-8. [PMID: 3449423] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
|
35
|
Zhang ST, Li GF, Cao JH. [Total correction of tetralogy of Fallot]. Zhonghua Wai Ke Za Zhi 1987; 25:637-9, 669. [PMID: 3450496] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
|
36
|
Liu DX, Lin ZJ, Li GF, Gao XK. [Optimal conditions and affecting factors on adhesion of Campylobacter jejuni to HeLa cells]. Hua Xi Yi Ke Da Xue Xue Bao 1987; 18:218-21. [PMID: 3679170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
|
37
|
Wang HZ, Shao DZ, Li GF. [Detection and application of autoantibody to centromere in chromosome spread]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 1986; 8:404-6. [PMID: 2952316] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
|
38
|
Ye SZ, Li GF, Chi ZQ. [Autoradiography of [3H]ohmefentanyl binding with opiate receptors in the rat brain]. Zhongguo Yao Li Xue Bao 1986; 7:193-8. [PMID: 3035868] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
|
39
|
Liu GZ, Song YH, Pan WR, Chen YF, Li GF, Bai Y, Zhang ZJ. [Radioimmunoassay of T3, T4, T3u, FTI and TSH in diagnosis of thyroid diseases]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 1984; 6:375-7. [PMID: 6241093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
|
40
|
Zhou YQ, Li GF, Zhong JX, Dong ZF, Gao XS. [Antimalarial activity of some 2,4-diamino-6-substituted amino sulfonyl quinazoline derivatives]. Yao Xue Xue Bao 1984; 19:245-50. [PMID: 6496100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
|
41
|
Liu GZ, Song YH, Pan WR, Li GF, Liu CS, Bai Y, Zhang ZJ, Li ZH. [Changes in serum levels of T4, T3 and TSH in TRH stimulation test among normal adults]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 1983; 5:290-4. [PMID: 6234078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
|
42
|
Ye SZ, Li GF, Chi ZQ. [Autoradiographic studies on binding of glycolate esters with muscarinic cholinergic receptors in mouse brain (author's transl)]. Zhongguo Yao Li Xue Bao 1982; 3:1-5. [PMID: 6211895] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
|
43
|
Zhao DC, Zhong JX, Geng RL, Li GF, Ding DB, Deng RX. [Studies on antimalarials. II. Synthesis of alpha-alkylaminomethyl-1, 6-dichloro-4-fluorenemethanols (author's transl)]. Yao Xue Xue Bao 1982; 17:28-32. [PMID: 7090823] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
|
44
|
Li GF. [Role of catecholamines in the occurrence of ventricular fibrillation (author's transl)]. Zhonghua Xin Xue Guan Bing Za Zhi 1981; 9:150-2. [PMID: 7318670] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
|